Posts In: Gubba Pharma In E News

Cipla eyes acquisitions, inorganic partnerships in US market

Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in the domestic market. The Mumbai-based...

Continue Reading

Consensus Guidelines for the Management of Head & Neck Cancer recognised among 13 worldwide clinical practice guidelines

The Consensus Guidelines for the Management of Head and Neck Cancer (HNC), developed under the aegis of Oral Cancer Task Force (OCTF) supported by the...

Continue Reading

Glenmark partners with Pfizer to launch Abrocitinib in India

Pfizer and Glenmark Pharmaceuticals have joined hands to launch abrocitinib, an oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. Developed by Pfizer,...

Continue Reading

Turkish Cargo Unveils Innovative Pharmaceutical Logistics Solutions

Turkish Cargo, a prominent player in the global air cargo industry, has introduced three new products in the pharmaceutical logistics sector: TK Pharma Standard, TK...

Continue Reading

ENTOD Pharma launches new R&D centre in Navi Mumbai

ENTOD Pharmaceuticals has inaugurated its state-of-the-art Research & Development Centre in Navi Mumbai. The DSIR approved research laboratory is equipped with the molecular and formulation...

Continue Reading

Lupin, American College of Cardiology introduce digital therapeutics certificate for cardiologists in India

Lupin Digital Health, India’s first evidence-based cardiology Digital Therapeutics (DTx) platform and the American College of Cardiology (ACC), the global scientific leader in the practice...

Continue Reading

Indian Immunologicals Launches First Indigenously Developed Hepatitis A Vaccine, ‘Havisure’

Indian Immunologicals Ltd. (IIL), a wholly-owned subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company in India, launched India’s first indigenously developed...

Continue Reading

Zydus Life signs exclusive licensing and supply agreement for breast cancer drug

Zydus Lifesciences Ltd. has announced that its wholly-owned subsidiary, has entered into an exclusive licensing and supply agreement with Synthon for Palbociclib Tablets for the...

Continue Reading

IISc develops heat-tolerant vaccine for protection against different strains of SARS-CoV-2 & future variants

The Indian Institute of Science (IISc) is now developing a heat-tolerant vaccine that can offer protection against different strains of SARS-CoV-2 – both current and...

Continue Reading